Stock A229500 NOVMETAPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News NovMetaPharma Co., Ltd.

Equities

A229500

KR7229500004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
6,230 KRW 0.00% Intraday chart for NovMetaPharma Co., Ltd. -8.11% -69.61%
May. 27 NovMetaPharma Co., Ltd. cancelled the acquisition of SK Securities No.8 Special Purpose Acquisition Company in a reverse merger transaction. CI
2023 NovMetaPharma Co., Ltd. agreed to acquire SK Securities No.8 Special Purpose Acquisition Company in a reverse merger transaction CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NovMetaPharma Co., Ltd. cancelled the acquisition of SK Securities No.8 Special Purpose Acquisition Company in a reverse merger transaction.
CI
NovMetaPharma Co., Ltd. agreed to acquire SK Securities No.8 Special Purpose Acquisition Company in a reverse merger transaction
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 6.99999258 billion in funding from BNC Korea Co., Ltd.
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 6.99999258 billion in funding from BNC Korea Co., Ltd.
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 3.299969948 billion in funding from Road Jeilho Bio Private Equity Joint Venture Company
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 3.299969948 billion in funding from Road Jeilho Bio Private Equity Joint Venture Company and other investors
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 3.8000182 billion in funding from Heungkuk Life Insurance Co., Ltd.
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 3.8000182 billion in funding from Heungkuk Life Insurance Co., Ltd.
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 3 billion in funding
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 3 billion in funding
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 4.511234288 billion in funding from Intellectual Discovery Co., Ltd.
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 4.511234288 billion in funding from Intellectual Discovery Co., Ltd.
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 10.22 billion in funding from KMH Co. Ltd., Whale Investment and other investors
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 10.22 billion in funding from KMH Co. Ltd., Whale Investment and other investors
CI
NovMetaPharma Co., Ltd. announced that it has received KRW 1.86 billion in funding
CI
NovMetaPharma Co., Ltd. announced that it expects to receive KRW 1.86 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A229500 Stock
  4. News NovMetaPharma Co., Ltd.